Recon: Allergan to Recall Textured Breast Implants in Canada; FDA Expands Revlimid Label - Regulatory Focus

Recon: Allergan to Recall Textured Breast Implants in Canada; FDA Expands Revlimid Label  Regulatory Focus

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US. J&J's greed helped fuel US opioid crisis, Oklahoma ...